Drug Discovery Day 2024

Recent technological advancements such as spatial biology, single-cell genomics and complex in vitro models are revolutionizing the way drugs are developed. In this session, David Walt, Ph.D. and Carly Strelez, Ph.D. will shine light on how drug discovery and personalized medicine are being transformed by next-generation biotech tools.

An in-depth discussion with Endpoints Senior Science Correspondent Ryan Cross and Arena Bioworks co-founder Stuart Schreiber. Featuring a conversation around small molecule drug discovery, AI in chemical biology, and new models of funding science.

Across the pharmaceutical industry, there is a broad need for improved efficiency to increase the translation of science from bench to clinic. One area that is ripe for improvement is the predictiveness of preclinical models. Join this session to hear a panel of experts discuss how complex in vitro models are helping to improve efficacy and ADME-Tox evaluation of drug candidates to bridge the translational gap.

 
Our expert speakers will highlight how they have used Organ-Chips to study viral and bacterial infections, including SARS-CoV-2, Nipah virus and Mycobacterium tuberculosis. Join to learn how to gain deeper insights into infectious disease pathogenesis, infection-induced inflammatory response, and more.